NAUTILUS BIOTECH
Nautilus Biotech is a biotechnology company. The company has a pipeline of therapeutic proteins with improved profiles. The company's products include Belerofon, an injectable and orally available interferon alpha for use in the treatment of chronic Hepatitis C infection; and Vitatropin, an injectable and orally available human growth hormone (hGH) for use in the treatment of growth deficiencies. Nautilus Biotech S.A. sells therapeutic proteins, including interferons, hormones, growth factors, and enzymes in France and internationally. The company's protein engineering technology improves the pharmacology profile and administration route of blockbuster protein drugs. Nautilus Biotech S.A. was founded in 1999 and is based in Evry, France.
NAUTILUS BIOTECH
Industry:
Biopharma Biotechnology Therapeutics
Founded:
1999-01-01
Address:
Évry, Ile-de-France, France
Country:
France
Total Employee:
11+
Status:
Active
Total Funding:
20.81 M USD
Similar Organizations
Bayhill Therapeutics
Bayhill Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapeutics.
CureVac
CureVac is a clinical-stage biopharmaceutical company that provides prophylactic and therapeutic application of messenger RNA.
Investors List
Rothschild & Co.
Rothschild & Co. investment in Venture Round - Nautilus Biotech
Matignon Investissement & Gestion
Matignon Investissement & Gestion investment in Venture Round - Nautilus Biotech
Creabilis
Creabilis investment in Venture Round - Nautilus Biotech
123Venture
123Venture investment in Venture Round - Nautilus Biotech
Auriga Partners
Auriga Partners investment in Venture Round - Nautilus Biotech
Auriga Partners
Auriga Partners investment in Venture Round - Nautilus Biotech
Matignon Investissement & Gestion
Matignon Investissement & Gestion investment in Venture Round - Nautilus Biotech
Andera Partners
Andera Partners investment in Venture Round - Nautilus Biotech
123Venture
123Venture investment in Venture Round - Nautilus Biotech